Hydrochloric Acid

Hydrochloric Acid

SCHEMBL4728720

CC(Cl)Cl.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methane SCHEMBL27537408 0.94
Hydrochloric Acid SCHEMBL28183434 0.94
Hydrochloric Acid SCHEMBL28019499 0.94
SCHEMBL11523834 0.93
SCHEMBL5438089 0.93
SCHEMBL126 0.93
SCHEMBL5728116 0.93
Hydrochloric Acid SCHEMBL5846270 0.93
Chloromethane SCHEMBL5050446 0.86
SCHEMBL8156740 0.86

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111729129-B Fine manufacturing of light-operated hybrid cross-linked degradable scaffold and application of light-operated hybrid cross-linked degradable scaffold in bone tissue engineering 四川大学 2022-10-04 CN claimed
CN-104163983-A Ramie fiber-reinforced polypropylene composite material and preparation process thereof HEILONGJIANG XINDA ENTPR GROUP CO LTD 2014-11-26 CN claimed
CN-111729129-B Fine manufacturing of light-operated hybrid cross-linked degradable scaffold and application of light-operated hybrid cross-linked degradable scaffold in bone tissue engineering 四川大学 2022-10-04 CN disclosed
CN-111729129-A Fine manufacturing of light-operated hybrid cross-linked degradable scaffold and application of light-operated hybrid cross-linked degradable scaffold in bone tissue engineering 四川大学 2020-10-02 CN disclosed
CN-209596869-U A kind of processing unit of malononitrile reaction end gas Hebei chengxin co ltd 2019-11-08 CN disclosed
CN-110194939-A High-thermal-conductivity and insulating two-component epoxy pouring sealant and using method thereof 苏州太湖电工新材料股份有限公司 2019-09-03 CN disclosed
CN-107780987-A Turbine suitably a variety of working medium plasma method reheating and magnetic fluid cogeneration and Poly-generation 贾建立 2018-03-09 CN disclosed
CN-104211654-B A kind of preparation method and intermediate of Rivaroxaban intermediate 联化科技(台州)有限公司 2017-03-29 CN disclosed
CN-103357242-B Method for purifying and removing chlorides contained in chlorine-containing industrial mixed gas and recovering light hydrocarbon CHINA NATIONAL OFFSHORE OIL CORPORATION (CN) 2014-10-08 CN disclosed
CN-102701991-B Method for preparing nonane diamine Hebei yanuo chemical industry co ltd 2013-12-18 CN disclosed
CN-103357242-A Method for purifying and removing chlorides contained in chlorine-containing industrial mixed gas and recovering light hydrocarbon CHINA NAT OFFSHORE OIL CORP 2013-10-23 CN disclosed
CN-102701991-A Method for preparing nonane diamine HEBEI YANUO CHEMICAL CO LTD 2012-10-03 CN disclosed
CN-102463125-A Olefin oxychlorination catalyst, preparation method thereof and method for preparing dichloroethane CHINA PETROLEUM & CHEMICAL 2012-05-23 CN disclosed
CN-102463116-A Olefin oxychlorination catalyst, preparation method thereof and preparation method of dichloroethane CHINA PETROLEUM & CHEMICAL 2012-05-23 CN disclosed
WO-2008036967-A2 NOVEL HETEROCYCLIC COMPOUNDS AS LASY ACTIVATORS REDDY US THERAPEUTICS, INC. (US) 2008-03-27 WO disclosed
CN-101137375-A Anti-inflammatory compounds NOVARTIS AG (CH) 2008-03-05 CN disclosed
CN-101137374-A Combination of a steroid sulfatase inhibitor and an ascomycin NOVARTIS AG (CH) 2008-03-05 CN disclosed